Initially I was dissappointed by earnings being pushed out to end of this month. Also I was disspointed by lack of price movement, But I am jumping back in pre-announcement.
Pushing the the earnings release until the end of the month can be for a number of reasons;
1) Getting ready for a potential buyout
2) Moving off Pinksheets to another exchange ( Ilya Nikolayev has mentioned this desire in the past to improve investor equity)
3) Forecast earnings for the next qtr and next year, like a real company
Any of these reasons requires the books to be as acccurate as possible. They have never really provided forecast numbers in the past and they likely weren't on the position to have good future visibility. Now they do so this could be the #1 reason for getting the numbers straight. Ilya has a strong reason to get TAPM above $1.
My best guess is that Ilya wants to move from Pinks Sheets to OTCBB, which requires filing a quarterly financial report with the SEC, while companies on Pink Sheets are not required to report financial statements. This would easily explain taking longer in March to ensure they report quarterly thereafter.
Though I don't like reverse split, the news today will start pumping money into GBSN and the reverse split will become a distant memory.
Sentiment: Strong Buy
Great Basin's Staph ID/R Blood Culture Panel is a sample-to-result, automated, DNA multiplex assay for simultaneous identification of Staphylococcus aureus and Staphylococcus species directly from positive blood cultures in about 2 hours. The panel also detects the mecA gene, a major drug resistance marker that confers resistance to methicillin and other beta-lactams and creates the superbug MRSA.
Sentiment: Strong Buy
Looks like a few paid bashers "nandha" "amzn..." are polluting the board try to scare people and affect the stock price. The sad part is that their incessant negative comments and trading tactics do seem to affect a stocks price for a while.
It is easier for them to move a low stock like EGRX (6M float). Congrats so far muck rakers.
Barclays downgraded with a price target of $15 while Credit Suisse upgraded with a target of $23.
No can agree where to price this, that is why the wild swings.
... is day traders. When I start hearing people say they just bought 8,000 or 10,000 shares or are averaging down on a thinly traded/low float stock.... that is usually a bad omen.
The reason is because those traders are willing to dump their share 1) when PPS rises a 20-30 cents thus muting upward movement. 2) when PPS starts to fade they bail and cut their losses. thus sending stock to new lows.
I hope I am wrong, but I think PSG will sink below $3 due to day traders' impatience.
In reality, announcing 125k instead of 135k for the qtr and also payong down debt shouldn't equate to a 64% drop, But this is not reality, this is day trading.
Two firms reduced the price target to $6, which is almost double the current stock price. LOL
Current PPS is over done. But that doesn't mean it can't go lower.
what to do what to do...
The float has turned in the last 3 days. Float is only 10 Million. 3.3 Million traded today so far and only 2.6 Million. That means no long time sellers left. This is just day traders playing with it now. They can still take this lower of course. But all sellers who would effect real momentum are gone.
ASPS was over $35 on Friday Then the plummet started ...$25 on Monday, then $19 on Tuesday. Today it is down to low $18's after initially gaping higher. There is still some risk with ASPS. But the PPS after 3 days of selling has improved the risk/reward prospects. Dipping my toe at these levels.
only a 10 million share float. It has traded 6-7 million in last 2 days. Not many long term holders left I would guess. Mostly day traders yesterday and today. A low float stock is easy to manipulate by some traders.
Endo International PLC said it would shutter its litigation-burdened Astora Women's Health division at the end of March after failing to find a buyer.
They finally got this albotross off their neck. They have some claims/settlement issues still. But long term ENDP looks brighter after dumping Astora.
Well, if they are trying to keep their business and earnings a secret, they are doing an awesome job. The only hope I have for waiting such a long time to release earnings is that are getting the t's and c's straight on be acquired.